Circulating Tumor DNA

The model improved on earlier CRC models by including ctDNA-related recurrence risk. ctDNA affected recurrence risk but did not alter surveillance schedules in the model. Patients who were ctDNA-positive after surgery had higher recurrence risk than ctDNA-negative patients. ctDNA was modeled as a marker of residual tumor cells after surgery.